Victor E Nava

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 17

Top Topics

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Radical Prostatectomy

Top Venues

Current oncology (Toronto, Ont.)

SN comprehensive clinical medicine

International journal of laboratory hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Daniel Karel, Claire Valburg, Navitha Woddor, Victor E Nava, Anita Aggarwal
Myelodysplastic Neoplasms (MDS): The Current and Future Treatment Landscape. Current oncology (Toronto, Ont.) 31 (4) (2024)
Alexandra Zara Rozalen, Jose Manuel Martin, Rithika Rajendran, Maneesh Jain, Victor E Nava
Ductal Adenocarcinoma of the Prostate with Novel Genetic Alterations Characterized by Next-Generation Sequencing. Current oncology (Toronto, Ont.) 31 (3) (2024)
Daniel Karel, Claire Valburg, Navitha Woddor, Victor E Nava, Anita Aggarwal
Myelodysplastic Neoplasms (MDS): The Current and Future Treatment Landscape. Current oncology (Toronto, Ont.) 31 (4) (2024)
Daniel Karel, Claire Valburg, Navitha Woddor, Victor E Nava, Anita Aggarwal
Myelodysplastic Neoplasms (MDS): The Current and Future Treatment Landscape. Current oncology (Toronto, Ont.) 31 (4) (2024)
Alexandra Zara Rozalen, Jose Manuel Martin, Rithika Rajendran, Maneesh Jain, Victor E Nava
Ductal Adenocarcinoma of the Prostate with Novel Genetic Alterations Characterized by Next-Generation Sequencing. Current oncology (Toronto, Ont.) 31 (3) (2024)
Alexandra Zara Rozalen, Jose Manuel Martin, Rithika Rajendran, Maneesh Jain, Victor E Nava
Ductal Adenocarcinoma of the Prostate with Novel Genetic Alterations Characterized by Next-Generation Sequencing. Current oncology (Toronto, Ont.) 31 (3) (2024)
Daniel Karel, Claire Valburg, Navitha Woddor, Victor E Nava, Anita Aggarwal
Myelodysplastic Neoplasms (MDS): The Current and Future Treatment Landscape. Current oncology (Toronto, Ont.) 31 (4) (2024)
Daniel Karel, Claire Valburg, Navitha Woddor, Victor E Nava, Anita Aggarwal
Myelodysplastic Neoplasms (MDS): The Current and Future Treatment Landscape. Current oncology (Toronto, Ont.) 31 (4) (2024)
Alexandra Zara Rozalen, Jose Manuel Martin, Rithika Rajendran, Maneesh Jain, Victor E Nava
Ductal Adenocarcinoma of the Prostate with Novel Genetic Alterations Characterized by Next-Generation Sequencing. Current oncology (Toronto, Ont.) 31 (3) (2024)
Haitham Alaithan, Nirbhay Kumar, Mohammad Z Islam, Angelike P Liappis, Victor E Nava
Novel Therapeutics for Malaria. Pharmaceutics 15 (7) (2023)
Kyle C Roche, Peter A DeRosa, Min-Ling Liu, Victor E Nava, Anita Aggarwal
Refractory Splenic Marginal Zone Lymphoma Responsive to Combination Venetoclax and Bortezomib (Velcade) (V 2 ) Therapy. Current oncology (Toronto, Ont.) 29 (6) (2022)
Maryam Mehdipour Dalivand, Parastou Tizro, Julie Partain, Anita Aggarwal, Jack Lichy, Francisco Mot Ara, Victor E Nava
Concurrent B Cell Acute Lymphoblastic Lymphoma/Leukemia and Monoclonal B Cell Lymphocytosis: A Case Report with Extensive Molecular Analysis. Case reports in hematology 2022 (2022)
Hira Akhlaq, Mian Li, Victor E Nava
Secondary Stabbing Headache Associated with COVID-19: a Case Report. SN comprehensive clinical medicine 4 (1) (2022)
Victor E Nava, Pin-Yu Perera, Nirbhay Kumar, Maneesh Jain
Noncoding-RNA-Based Therapeutics with an Emphasis on Prostatic Carcinoma-Progress and Challenges. Vaccines 10 (2) (2022)
Peter A DeRosa, Kyle C Roche, Victor E Nava, Sunita Singh, Min-Ling Liu, Anita Agarwal
Concurrent Waldenstrom's Macroglobulinemia and Myelodysplastic Syndrome with a Sequent t(10;13)(p13;q22) Translocation. Current oncology (Toronto, Ont.) 29 (7) (2022)
Victor E Nava
Introduction to a Special Issue on Low-Grade B Cell Lymphoma in the Spleen. Current oncology (Toronto, Ont.) 29 (1) (2021)
Maryam Mehdipour Dalivand, Parastou Tizro, Anita Aggarwal, Victor E Nava
Increased CD23 expression in postsplenectomy polyclonal B-Cell lymphocytosis. International journal of laboratory hematology (2021)